Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.01
-0.89 (-8.99%)
May 9, 2025, 1:37 PM - Market open

Theravance Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
130.8637.839.55298.1789.9681.47
Upgrade
Short-Term Investments
-50.5562.8829.3183.51211.47
Upgrade
Cash & Short-Term Investments
130.8688.35102.43327.48173.47292.94
Upgrade
Cash Growth
30.89%-13.74%-68.72%88.79%-40.78%4.31%
Upgrade
Accounts Receivable
15.3518.4417.4716.7914.0715.87
Upgrade
Other Receivables
-50---53.8
Upgrade
Receivables
15.3568.4417.4716.7914.0769.67
Upgrade
Prepaid Expenses
4.064.2813.649.218.8130.73
Upgrade
Other Current Assets
----43.53-
Upgrade
Total Current Assets
150.26161.07133.54353.46249.87393.34
Upgrade
Property, Plant & Equipment
34.4635.7745.365253.3559.68
Upgrade
Long-Term Investments
-----12.75
Upgrade
Other Long-Term Assets
158.86157.32203.1201.9471.63.28
Upgrade
Total Assets
343.58354.16382607.4374.82469.06
Upgrade
Accounts Payable
-2.241.521.553.16.78
Upgrade
Accrued Expenses
-13.2812.8320.4137.9576.07
Upgrade
Current Portion of Long-Term Debt
----16.9419.33
Upgrade
Current Portion of Leases
-10.713.926.750.59.87
Upgrade
Current Income Taxes Payable
-5.85----
Upgrade
Current Unearned Revenue
----0.111.52
Upgrade
Other Current Liabilities
31.5-6.49---
Upgrade
Total Current Liabilities
31.532.0924.7728.7258.59123.57
Upgrade
Long-Term Debt
----599.39599.84
Upgrade
Long-Term Leases
37.3539.1145.2445.4152.6847.22
Upgrade
Long-Term Unearned Revenue
---0.190.310.35
Upgrade
Other Long-Term Liabilities
108.75107.429991.292.421.83
Upgrade
Total Liabilities
177.6178.62169165.6713.39772.81
Upgrade
Common Stock
165.98--000
Upgrade
Additional Paid-In Capital
-1,1411,1221,2961,3871,223
Upgrade
Retained Earnings
--965.52-909.1-853.91-1,726-1,527
Upgrade
Comprehensive Income & Other
-0.01-0.07-0.02-0.05
Upgrade
Shareholders' Equity
165.98175.55213441.8-338.57-303.75
Upgrade
Total Liabilities & Equity
343.58354.16382607.4374.82469.06
Upgrade
Total Debt
37.3549.8249.1652.16669.52676.26
Upgrade
Net Cash (Debt)
93.5138.5353.27275.32-496.05-383.32
Upgrade
Net Cash Growth
79.57%-27.67%-80.65%---
Upgrade
Net Cash Per Share
1.900.790.963.74-7.14-6.15
Upgrade
Filing Date Shares Outstanding
49.7149.4748.1662.8674.764.33
Upgrade
Total Common Shares Outstanding
49.7149.4748.0965.2374.4464.33
Upgrade
Working Capital
118.76128.98108.77324.75191.28269.77
Upgrade
Book Value Per Share
3.343.554.436.77-4.55-4.72
Upgrade
Tangible Book Value
165.98175.55213441.8-338.57-303.75
Upgrade
Tangible Book Value Per Share
3.343.554.436.77-4.55-4.72
Upgrade
Machinery
-3.743.6819.0426.0335.88
Upgrade
Leasehold Improvements
-25.3226.2124.5824.0524.28
Upgrade
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q